Inhibition of stromal CXCR4 impairs development of lung metastases

Cancer Immunology, Immunotherapy

Volumn 61, Issue 10, 2012, Pages 1713-1720

  D'Alterio, Crescenzo ^a   Barbieri, Antonio ^a   Portella, Luigi ^a   Palma, Giuseppe ^a   Polimeno, Marianeve ^a   Riccio, Anna ^a   Ieranó, Caterina ^a   Franco, Renato ^a   Scognamiglio, Giosué ^a   Bryce, Jane ^a   Luciano, Antonio ^a   Rea, Domenica ^a   Arra, Claudio ^a   Scala, Stefania ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

CXCR4; Heterozygote mice; Melanoma; Plerixafor; Pulmonary metastases

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MITOGEN ACTIVATED PROTEIN KINASE P38; PLERIXAFOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ANALYSIS; FEMALE; GRANULOCYTE; HETEROZYGOTE; LUNG METASTASIS; LUNG NODULE; LUNG STRUCTURE; MELANOMA B16; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR MICROENVIRONMENT; WILD TYPE;

ANIMALS; ANTIGENS, LY; ANTINEOPLASTIC AGENTS; FEMALE; GRANULOCYTES; HETEROCYCLIC COMPOUNDS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RECEPTORS, CXCR4; STROMAL CELLS;

EID: 84867582756     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1223-7     Document Type: Article

References (42)

1. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inXammation. Nature 454:436-444
2. De Visser KE, Coussens LM (2006) The inXammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 13:118-137
3. Raman D, Baugher PJ, Thu YM, Richmond A (2007) Role of chemokines in tumor growth. Cancer Lett 256(2):137-165
4. Ben-Baruch A (2006) The multifaceted roles of chemokines in malignancy. Cancer Metas Rev 25(3):357-371
5. Vicari AP, Caux C (2002) Chemokines in cancer. Cytokine Growth Factor Rev 13(2):143-154
6. Balkwill F (2004) Cancer and the chemokine network. Nat Rev 4(7):540-550
7. Ehtesham M, Mapara KY, Stevenson CB, Thompson RC et al (2008) CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett 274(2):305-312
8. Lee BC, Lee TH, Avraham S, Avraham HK et al (2004) Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2(6):327-338
9. Mori T, Doi R, Koizumi M, Toyoda E, Ito D, Kami K (2004) CXCR4 antagonist inhibits stromal cell derived factor 1-induced migration and invasion of human pancreatic cell. Mol Cancer Ther 3:29-37
10. Chen GS, Yu HS, Lan CC, Chow KC, Lin TY, Kok LF et al (2006) CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Br J Dermatol 154:910-918
11. Bartolomé RA, Gálvez BG, Longo N, Baleux F, Van Muijen GN, Sánchez-Mateos P et al (2004) Stromal cell-derived factor-1 promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities. Cancer Res 64:2534-2543
12. Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P et al (2005) Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 5:1835-1841
13. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C (2005) Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23:2744-2753
14. Minamiya Y, Saito H, Takahashi N, Ito M, Imai K, Ono T (2010) Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung. Lung Cancer 68(3):466-471
15. D'Alterio C, Cindolo L, Portella L, Polimeno M, Consales C, Riccio A et al (2010) DiVerential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle 9(22):4492-4500
16. D'Alterio C, Consales C, Polimeno M, Franco R, Cindolo L, Portella L et al (2010) Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. Curr Cancer Drug Targets 10(7):772-781
17. Oda Y, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, Yokoyama R et al (2006) CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol 19:738-745
18. Perissinotto E, Cavalloni G, Leone F, Fonsato V, Mitola S, Grignani G et al (2005) Involvement of chemokine receptor 4/stromal derived factor 1 system during osteosarcoma tumour progression. Clin Cancer Res 11:490-497
19. Laverdiere C, Hoang BH, Yang R, Sowers R, Qin J, Meyers PA et al (2005) Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patient with osteosarcoma. Clin Cancer Res 11:25621-25627
20. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR (1997) The HIV coreceptors CXCR4 and CCR5 are diVerentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 94:1925-1930
21. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T (1993) Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261:600-603
22. Federsppiel B, Melhado IG, Duncan AM, Delaney A, Schappert K, Clark-Lewis I et al (1993) Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics 16(3):707-712
23. Ma Q, Jones D, Borghesani PR, Segal RS, Nagasawa T, Kishimoto T et al (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deWcient mice. Proc Natl Acad Sci USA 95:9448-9453
24. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y et al (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638
25. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y et al (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393:591-594
26. Zou Y, Kottman A, Kuroda M, Taniuchi I, Littman D (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595-599
27. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z et al (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203(9):2201-2213
28. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B et al (2005) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280(42):35760-35766
29. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev 6(5):392-401
30. Orimo A, Weinberg RA (2006) Stromal Wbroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5(15):1597-1601
31. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G et al (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169(5):2756-2761
32. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al (2005) Stromal Wbroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121(3):335-348
33. Bergfeld SA, DeClerck YA (2010) Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastat Rev 29(2):249-261
34. Murdoch C, Muthana M, CoVelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8:618-631
35. Hiratsuka S, Duda DG, Huang Y, Goel S, Sugiyama T, Nagasawa T, Fukumura D, Jain RK (2011) C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-Activated protein kinase in myeloid diVerentiation antigen (Gr-1)-positive cells. Proc Natl Acad Sci USA 108(1):302-307
36. Dawson MR, Duda DG, Fukumura D, Jain RK (2009) VEGFR1- activity-independent metastasis formation. Nature 461. doi:10. 1038/nature08254
37. Bendall LJ, Baraz R, Juarez J, Shen W, Bradstock KF (2005) Defective p38 mitogen-Activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor- 1+ in acute lymphoblastic leukemia. Cancer Res 65(8):3290- 3298
38. Kim SY, Lee CH, Midura BV, Yeung C, Mendoza A, Hong SH et al (2008) Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25(3):201-211
39. Burger JA, Stewart DJ, Wald O, Peled A (2011) Potential of CXCR4 antagonists for the treatment of metastatic lung cancer. Expert Rev Anticancer Ther 11(4):621-630 (review)
40. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ speciWc colonization. Nat Rev Cancer 9:274-284
41. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9(239-52):14
42. Parachikova A, Cotman CW (2007) Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease. Neurobiol Dis 2:143-153